Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteolytic processing of atriopeptin prohormone.

M L Michener, J K Gierse, R Seetharam

    Molecular Pharmacology
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cyclooxygenase assays.

    Current protocols in pharmacology·2011
    Same author

    Spontaneous intracerebral hemorrhage caused by an unusual association of developmental venous anomaly and arteriovenous malformation.

    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2010
    Same author

    Infraoptic anterior cerebral artery: review, report of two cases and an anatomical classification.

    Acta neurochirurgica·2008
    Same author

    Thrombosis of aggressive dural arteriovenous fistula after incomplete embolization.

    Neuroradiology·2004
    Same author

    Diffuse axonal injury: detection of changes in anisotropy of water diffusion by diffusion-weighted imaging.

    Neuroradiology·2003
    Same author

    Lipid remodeling in mouse liver and plasma resulting from delta6 fatty acid desaturase inhibition.

    Lipids·2002

    The rat heart contains enzymes to process atriopeptin prohormone into active atriopeptin. Blood enzymes are not required for this crucial metabolic pathway, indicating the heart

    Area of Science:

    • Biochemistry
    • Endocrinology
    • Molecular Biology

    Background:

    • Atriopeptin (ANF) is a peptide hormone involved in cardiovascular regulation.
    • The metabolism of the atriopeptin prohormone (ANF1-126) is not fully understood.
    • Investigating prohormone processing is key to understanding ANF's biological function.

    Purpose of the Study:

    • To elucidate the metabolic pathways of atriopeptin prohormone (ANF1-126).
    • To determine the role of cardiac and plasma enzymes in prohormone processing.
    • To identify the molecular forms of atriopeptin and its N-terminal fragment in circulation.

    Main Methods:

    • Utilized two radioimmunoassays to detect C-terminal atriopeptins and N-terminal fragments.
    • Analyzed rat plasma and atrial extracts using SDS-PAGE and immunoblotting.

    Related Experiment Videos

  • Employed a recombinant prohormone construct (ANF1-126-Arg-Arg) as a substrate for enzymatic cleavage studies.

    • Main Results:

    • Both atriopeptin and N-terminal fragment immunoreactivities were detected in rat plasma and elevated after desamino-arginine-vasopressin administration.
    • Atrial extracts contained a high molecular weight species reacting to both antisera, consistent with the prohormone.
    • Enzymatic cleavage of the recombinant prohormone by thrombin, isolated heart reperfusion, or serum yielded atriopeptin and the N-terminal fragment; plasma showed no significant metabolism.

    Conclusions:

    • The rat heart possesses enzymes capable of cleaving the atriopeptin prohormone into mature atriopeptin.
    • Processing of the prohormone primarily occurs within the heart, not requiring blood enzymes.
    • This study clarifies the endogenous processing mechanism of atriopeptin, essential for its physiological roles.